GSK
A Transatlantic Bet: Why a UK Pharma Titan is Doubling Down on the US
A UK pharma giant’s CEO champions US expansion, a powerful signal about global capital flow, policy, and the future of the UK’s innovation economy.
The Trillion-Dollar Bug: How AI and New Financial Models Are Fuelling the War on Superbugs
A new GSK-backed venture uses AI and innovative financial models to combat the growing economic and health threat of drug-resistant superbugs.
9 mins read
Beyond the Backlash: Why Smart Money is Still Betting on Corporate Diversity
DEI is not dead; it’s evolving. Explore the FT’s latest report on how smart money, long-term strategy, and financial data are reshaping corporate diversity.